Prenetics Global Limited (PRE) Financials
PRE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 276.4 million | 47.6 million |
| 2023-06-30 | 280.8 million | 60.6 million |
| 2023-03-31 | 308.0 million | 67.9 million |
| 2022-12-31 | 308.0 million | 67.9 million |
PRE Free Cash Flow and Stock based compensation
No data available :(
PRE Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-09-30 | -12.2 million |
| 2023-06-30 | -15.1 million |
| 2023-03-31 | 1.6 million |
| 2022-12-31 | 1.6 million |
PRE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 68.8 million | - | 5.3 million |
| 2023-06-30 | 190.8 million | - | 6.0 million |
| 2023-03-31 | 164.2 million | - | 6.4 million |
| 2022-12-31 | 164.2 million | - | 6.6 million |
PRE Shares Outstanding
PRE Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 4.0 million | 10.8 million | 1.7 million |
| 2023-06-30 | - | 2.7 million | 10.8 million | 2.2 million |
| 2023-03-31 | - | 3.6 million | 14.7 million | 2.5 million |
| 2022-12-31 | - | 3.6 million | 14.7 million | 2.5 million |
PRE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 4.9 million | 3.2 million |
| 2023-06-30 | 5.7 million | 3.6 million |
| 2023-03-31 | 52.3 million | 25.3 million |
| 2022-12-31 | 52.3 million | 25.3 million |
PRE
Price: $4.45
52 week price:
Payout Ratio Range:
Earnings Per Share: 4.35 USD
P/E Ratio: 1.07
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 162600
Market Capitalization: 49.4 million
Average Dividend Frequency: 4